Launch Strategy and Structure Research
Brand Management Excellence Services
 |
The importance of brand management has led to the emergence of an increasingly sophisticated system to adequately coordinate, communicate and execute the critical activities that propagate and sustain brand growth... (ID SMS-3)
Companies Profiled: 3M Pharmaceuticals, aaiPharma, Abbott Laboratories, Solvay America, more ...
Price: $29995.00 Free Excerpt Available
| |
Best Practices in Global Pharmaceutical Launches
 |
Discover how the world's leading pharmaceutical companies develop global launch strategies, manage launch teams, cultivate thought leader support, integrate marketing activities, and conduct a host of other critical launch activities... (ID SM-120)
Companies Profiled: Merck, Sanofi-aventis, Eli Lilly, Wyeth, more ...
Price: $7000.00 Free Excerpt Available
| |
Effient Case Study: Stumbling When Taking On The Market Leader
|
Non-members: Click here to review a complimentary excerpt from "Effient Case Study: Stumbling When Taking On The Market Leader"
STUDY OVERVIEW
The blood thinner Effient entered the market with expectations of becoming a blockbuster for Daiichi Sankyo and Eli Lilly... (ID 5107)
Companies Profiled: Eli Lilly, Daiichi Sankyo
Price: $4500.00 Free Excerpt Available
| |
Januvia Case Study: Building a Successful Launch Around KOL, Physician, Patient and Payer Education
|
Non-members: Click here to review a complimentary excerpt from "Januvia Case Study: Building a Successful Launch Around KOL, Physician, Patient and Payer Education"
STUDY OVERVIEW
Approved in 2006 as a treatment for Type II diabetes, Januvia is a first-in-class oral dipeptidyl peptidase-4 that was greeted enthusiastically at launch by prescribers, payers and patients... (ID 5106)
Companies Profiled: Merck
Price: $4500.00
| |
Gardasil Case Study: Using Policy as a Springboard for Launch Success
|
Non-members: Click here to review a complimentary excerpt from "Gardasil Case Study: Using Policy as a Springboard For Launch Success"
STUDY OVERVIEW
Gardasil is a vaccine manufactured by Merck that prevents certain diseases caused by the Human Papillomavirus (HPV), including cervical cancer and genital warts... (ID 5108)
Companies Profiled: Merck
Price: $3381.00 Free Excerpt Available
| |
Onglyza Case Study: Lack of Differentiation Mutes a Launch
|
Non-members: Click here to review a complimentary excerpt from "Onglyza Case Study: Lack of Differentiation Mutes a Launch"
STUDY OVERVIEW
Onglyza, a DPP-4 inhibitor class of anti-diabetes drug, was the second DPP-4 to the market behind the blockbuster Januvia... (ID 5109)
Companies Profiled: Bristol-Myers Squibb, AstraZeneca
Price: $2760.00 Free Excerpt Available
| |
Pharmaceutical Early-Stage Commercialization: Structure & Functions That Lead to Success
|
Non-members: Click here to review a complimentary excerpt of
"Pharmaceutical Early-Stage Commercialization: Structure & Functions that Lead to Success"
STUDY OVERVIEW
Long and costly product development cycles make it essential for pharmaceutical companies to maximize limited staff and resources to the development of compounds with the greatest potential market value... (ID 5020)
Companies Profiled: Abbott Laboratories, Allergan, Alexion Pharmaceuticals, Altus Biologics, more ...
Price: $2598.00 Free Excerpt Available
| |
| | |